Related Experiment Video
Updated: Apr 25, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Epstein-Barr virus in multiple sclerosis
Hisham S Abdelrahman1, Heba S Selim, Mona H Hashish
1aMicrobiology Department, High Institute of Public Health bNeurology and Psychiatry Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Background/Objectives:
Multiple sclerosis (MS) is an inflammatory disorder of the central nervous system. Many diseases are associated with Epstein-Barr virus (EBV) infection, such as infectious mononucleosis and many types of malignancies, and it is thought to be related to some diseases of autoimmune origin, such as rheumatoid arthritis, systemic lupus erythematosis, and others. The present study aimed to assess EBV in patients with MS.
Patients And Methods:
This case-control study was conducted from October 2012 to September 2013 on 75 MS patients and non-MS controls. Both were tested quantitatively for immunoglobulin G (IgG) antibodies against Epstein-Barr nuclear antigen-1 (EBNA1) and viral capsid antigen (VCA) using the enzyme linked immunosorbent assay technique.
Results:
Seventy MS patients (93.3%) were positive for EBNA1 IgG compared with 68 controls (90.7%). In MS patients, the mean EBNA1 IgG serum level was 310.91 (±131.05) U/ml; meanwhile, among controls the mean serum EBNA IgG level was 177.81 (±104.98) U/ml.All patients with MS were positive for VCA IgG, whereas only 60 (80.0%) controls were positive. In the MS group, the VCA IgG mean level was 302.19 (±152.11) U/ml compared with 167.94 (±111.79) U/ml in controls. The differences in the serum levels of both markers between the two groups were statistically significant (P<0.001).
Conclusion And Recommendations:
EBV proved to have a unique immunological pattern in MS patients when compared with non-MS controls. Further studies for more confirmation of the relation between EBV and MS on a large scale are recommended.
Insights
Epstein-Barr virus (EBV) shows a distinct immunological profile in multiple sclerosis (MS) patients. Higher levels of EBV antibodies were found in MS patients compared to controls, suggesting a potential link.
Area of Science:
- Neuroimmunology
- Virology
- Immunology
Background:
- Multiple sclerosis (MS) is a central nervous system inflammatory disorder.
- Epstein-Barr virus (EBV) is associated with various autoimmune and malignant diseases.
- A potential link between EBV and autoimmune conditions like MS warrants investigation.
Purpose of the Study:
- To quantitatively assess Epstein-Barr virus (EBV) immunoglobulin G (IgG) antibodies in patients diagnosed with multiple sclerosis (MS).
- To compare EBV antibody levels between MS patients and a control group without MS.
Main Methods:
- A case-control study involving 75 MS patients and 75 non-MS controls.
- Quantitative measurement of immunoglobulin G (IgG) antibodies against Epstein-Barr nuclear antigen-1 (EBNA1) and viral capsid antigen (VCA) using ELISA.
- Statistical analysis to compare antibody levels between MS patients and controls.
Main Results:
- Significantly higher prevalence and serum levels of EBNA1 IgG antibodies in MS patients (93.3%) compared to controls (90.7%).
- All MS patients (100%) tested positive for VCA IgG, versus 80% of controls.
- Statistically significant differences (P<0.001) in mean serum levels for both EBNA1 IgG and VCA IgG between MS patients and controls.
Conclusions:
- Epstein-Barr virus (EBV) exhibits a unique immunological signature in multiple sclerosis (MS) patients.
- The findings suggest a significant association between EBV and MS.
- Large-scale studies are recommended to further elucidate the relationship between EBV and MS.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Related Concept Videos
Multiple Sclerosis l: Introduction
Arboviral Encephalitis
Encephalitis ll: Pathophysiology
Cytomegalovirus Disease
Encephalitis l: Introduction